FLT4

Fms-related tyrosine kinase 4, also known as FLT4, is a human gene.cite web | title = Entrez Gene: FLT4 fms-related tyrosine kinase 4| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2324| accessdate = ]

PBB_Summary
section_title =
summary_text =

ee also

* VEGF receptors

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Petrova TV, Makinen T, Alitalo K |title=Signaling via vascular endothelial growth factor receptors. |journal=Exp. Cell Res. |volume=253 |issue= 1 |pages= 117–30 |year= 1999 |pmid= 10579917 |doi= 10.1006/excr.1999.4707
*cite journal | author=Aprelikova O, Pajusola K, Partanen J, "et al." |title=FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. |journal=Cancer Res. |volume=52 |issue= 3 |pages= 746–8 |year= 1992 |pmid= 1310071 |doi=
*cite journal | author=Galland F, Karamysheva A, Mattei MG, "et al." |title=Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. |journal=Genomics |volume=13 |issue= 2 |pages= 475–8 |year= 1992 |pmid= 1319394 |doi=
*cite journal | author=Pajusola K, Aprelikova O, Korhonen J, "et al." |title=FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. |journal=Cancer Res. |volume=52 |issue= 20 |pages= 5738–43 |year= 1992 |pmid= 1327515 |doi=
*cite journal | author=Fournier E, Dubreuil P, Birnbaum D, Borg JP |title=Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. |journal=Oncogene |volume=11 |issue= 5 |pages= 921–31 |year= 1995 |pmid= 7675451 |doi=
*cite journal | author=Pajusola K, Aprelikova O, Armstrong E, "et al." |title=Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. |journal=Oncogene |volume=8 |issue= 11 |pages= 2931–7 |year= 1993 |pmid= 7692369 |doi=
*cite journal | author=Pajusola K, Aprelikova O, Pelicci G, "et al." |title=Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. |journal=Oncogene |volume=9 |issue= 12 |pages= 3545–55 |year= 1994 |pmid= 7970715 |doi=
*cite journal | author=Galland F, Karamysheva A, Pebusque MJ, "et al." |title=The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. |journal=Oncogene |volume=8 |issue= 5 |pages= 1233–40 |year= 1993 |pmid= 8386825 |doi=
*cite journal | author=Fournier E, Rosnet O, Marchetto S, "et al." |title=Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase. |journal=J. Biol. Chem. |volume=271 |issue= 22 |pages= 12956–63 |year= 1996 |pmid= 8662748 |doi=
*cite journal | author=Lee J, Gray A, Yuan J, "et al." |title=Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=93 |issue= 5 |pages= 1988–92 |year= 1996 |pmid= 8700872 |doi=
*cite journal | author=Kukk E, Lymboussaki A, Taira S, "et al." |title=VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. |journal=Development |volume=122 |issue= 12 |pages= 3829–37 |year= 1997 |pmid= 9012504 |doi=
*cite journal | author=Achen MG, Jeltsch M, Kukk E, "et al." |title=Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 2 |pages= 548–53 |year= 1998 |pmid= 9435229 |doi=
*cite journal | author=Ferrell RE, Levinson KL, Esman JH, "et al." |title=Hereditary lymphedema: evidence for linkage and genetic heterogeneity. |journal=Hum. Mol. Genet. |volume=7 |issue= 13 |pages= 2073–8 |year= 1999 |pmid= 9817924 |doi=
*cite journal | author=Fournier E, Blaikie P, Rosnet O, "et al." |title=Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling. |journal=Oncogene |volume=18 |issue= 2 |pages= 507–14 |year= 1999 |pmid= 9927207 |doi= 10.1038/sj.onc.1202315
*cite journal | author=Karkkainen MJ, Ferrell RE, Lawrence EC, "et al." |title=Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. |journal=Nat. Genet. |volume=25 |issue= 2 |pages= 153–9 |year= 2000 |pmid= 10835628 |doi= 10.1038/75997
*cite journal | author=Irrthum A, Karkkainen MJ, Devriendt K, "et al." |title=Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. |journal=Am. J. Hum. Genet. |volume=67 |issue= 2 |pages= 295–301 |year= 2000 |pmid= 10856194 |doi=
*cite journal | author=Wang JF, Zhang XF, Groopman JE |title=Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. |journal=J. Biol. Chem. |volume=276 |issue= 45 |pages= 41950–7 |year= 2001 |pmid= 11553610 |doi= 10.1074/jbc.M101370200
*cite journal | author=Baldwin ME, Roufail S, Halford MM, "et al." |title=Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis. |journal=J. Biol. Chem. |volume=276 |issue= 47 |pages= 44307–14 |year= 2001 |pmid= 11574540 |doi= 10.1074/jbc.M106188200
*cite journal | author=Walter JW, North PE, Waner M, "et al." |title=Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. |journal=Genes Chromosomes Cancer |volume=33 |issue= 3 |pages= 295–303 |year= 2002 |pmid= 11807987 |doi=

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes